Usana Health Sciences Inc revenue
Usana Health Sciences Inc's revenue was $925m in fiscal 2025, up 8.3% on the year before. Since fiscal 2009 ($437m) it has grown at a compound 4.8% a year. Over the last twelve months it was $913m.
Revenue history
| Fiscal year | 2009Jan 2010 | 2010Jan 2011 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Jan 2015 | 2015Jan 2016 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Jan 2021 | 2021Jan 2022 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Jan 2026 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 437 | 518 | 582 | 649 | 718 | 790 | 918 | 1,006 | 1,047 | 1,189 | 1,061 | 1,135 | 1,186 | 999 | 921 | 855 | 925 | 913 |
| Growth on the year before | — | +18.5% | +12.4% | +11.5% | +10.7% | +10.1% | +16.2% | +9.5% | +4.1% | +13.6% | −10.8% | +7.0% | +4.6% | −15.8% | −7.8% | −7.2% | +8.3% | — |
| Gross profit | 347 | 422 | 480 | 533 | 591 | 650 | 759 | 826 | 868 | 989 | 873 | 926 | 969 | 805 | 744 | 693 | 724 | 707 |
| Gross margin | 79.4% | 81.6% | 82.5% | 82.1% | 82.3% | 82.2% | 82.6% | 82.1% | 82.9% | 83.1% | 82.3% | 81.6% | 81.6% | 80.6% | 80.8% | 81.1% | 78.3% | 77.4% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Core Nutritional | $775M | 83.8% | ▼ 8.3% |
| Hiya | $132M | 14.3% | ▲ 6599.0% |
| All Other | $17.8M | 1.9% | ▲ 164.4% |
| Region | Revenue | YoY |
|---|---|---|
| Asia Pacific | $627M | ▼ 8.2% |
| Greater China | $425M | ▼ 7.3% |
| China | $382M | ▼ 7.7% |
| Americas and Europe | $298M | ▲ 73.8% |
| United States | $225M | ▲ 145.0% |
| Southeast Asia Pacific | $132M | ▼ 10.1% |
| North Asia | $70.6M | ▼ 9.7% |
| South Korea | $68.9M | ▼ 9.9% |
These categories overlap or exclude eliminations, so shares aren't shown.
From Usana Health Sciences Inc's 10-K filed March 16, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Usana Health Sciences Inc | $913m | 1.6% | -1.2% |
| Oddity Tech Ltd | $810m | 25.2% | — |
| NU Skin Enterprises, Inc. | $1.38bn | -15.4% | -12.3% |
| Interparfums Inc | $1.50bn | 2.9% | 7.4% |
| Natures Sunshine Products Inc | $492m | 6.8% | 4.4% |
| E.l.f. Beauty, Inc. | $1.76bn | 31.2% | 37.9% |
Compare with peers
- Oddity Tech Ltd revenue
- NU Skin Enterprises, Inc. revenue
- Interparfums Inc revenue
- Natures Sunshine Products Inc revenue
- E.l.f. Beauty, Inc. revenue
Head to head: ODD vs USNANUS vs USNAIPAR vs USNANATR vs USNA
More: Personal Care Products stocks compared, Consumer Staples sector, rankings of US companies